Spiriva HandiHaler is a Oral; Respiratory (inhalation) Capsule in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Tiotropium Bromide Monohydrate.
| Product ID | 0597-0075_61e158db-bf32-4cb5-8e5e-72acd953e493 |
| NDC | 0597-0075 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Spiriva HandiHaler |
| Generic Name | Tiotropium Bromide |
| Dosage Form | Capsule |
| Route of Administration | ORAL; RESPIRATORY (INHALATION) |
| Marketing Start Date | 2005-10-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021395 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | TIOTROPIUM BROMIDE MONOHYDRATE |
| Active Ingredient Strength | 18 ug/1 |
| Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2005-10-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-01-29 |
| Marketing End Date | 2011-07-28 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-10-11 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-01-29 |
| Marketing End Date | 2011-07-28 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-01-29 |
| Marketing End Date | 2011-07-28 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-10-11 |
| Marketing End Date | 2017-10-25 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-10-11 |
| Marketing Category | NDA |
| Application Number | NDA021395 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-10-11 |
| Ingredient | Strength |
|---|---|
| TIOTROPIUM BROMIDE MONOHYDRATE | 18 ug/1 |
| SPL SET ID: | 820839ef-e53d-47e8-a3b9-d911ff92e6a9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0075 | Spiriva | TIOTROPIUM BROMIDE |
| 50090-4248 | Spiriva | TIOTROPIUM BROMIDE |
| 50090-4414 | Spiriva | TIOTROPIUM BROMIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SPIRIVA 79002090 2998420 Dead/Cancelled |
Boehringer Ingelheim Pharma GmbH & Co. KG 2004-03-18 |
![]() SPIRIVA 78335207 3005009 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. KG 2003-12-02 |
![]() SPIRIVA 75575954 2285506 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. K 1998-10-22 |